XRTX Annual Working Capital
$3.77 M
-$5.58 M-59.67%
01 December 2023
Summary:
As of January 23, 2025, XRTX annual working capital is $3.77 million, with the most recent change of -$5.58 million (-59.67%) on December 1, 2023. During the last 3 years, it has risen by +$2.97 million (+370.85%). XRTX annual working capital is now -75.29% below its all-time high of $15.27 million, reached on December 31, 2021.XRTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XRTX Quarterly Working Capital
$693.60 K
-$2.14 M-75.54%
01 September 2024
Summary:
As of January 23, 2025, XRTX quarterly working capital is $693.60 thousand, with the most recent change of -$2.14 million (-75.54%) on September 1, 2024. Over the past year, it has dropped by -$3.08 million (-81.62%). XRTX quarterly working capital is now -95.48% below its all-time high of $15.36 million, reached on December 1, 2021.XRTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XRTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.7% | -81.6% |
| 3 y3 years | +370.9% | -90.9% |
| 5 y5 years | +6384.4% | -90.9% |
XRTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.3% | at low | -95.5% | at low |
| 5 y | 5-year | -75.3% | +1117.5% | -95.5% | +119.7% |
| alltime | all time | -75.3% | +553.7% | -95.5% | +119.7% |
XORTX Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $693.60 K(-75.5%) |
| June 2024 | - | $2.84 M(-34.4%) |
| Mar 2024 | - | $4.32 M(+14.5%) |
| Dec 2023 | $3.77 M(-59.7%) | $3.77 M(-19.2%) |
| Sept 2023 | - | $4.67 M(-21.8%) |
| June 2023 | - | $5.97 M(-21.5%) |
| Mar 2023 | - | $7.61 M(-18.9%) |
| Dec 2022 | $9.36 M(-38.7%) | $9.38 M(+16.6%) |
| Sept 2022 | - | $8.05 M(-20.3%) |
| June 2022 | - | $10.10 M(-19.8%) |
| Mar 2022 | - | $12.60 M(-18.0%) |
| Dec 2021 | $15.27 M(+1805.5%) | - |
| Dec 2021 | - | $15.36 M(-537.0%) |
| Sept 2021 | - | -$3.51 M(-241.3%) |
| June 2021 | - | $2.49 M(-3.1%) |
| Mar 2021 | - | $2.57 M(+220.3%) |
| Dec 2020 | $801.50 K(-316.1%) | $801.50 K(-23.4%) |
| Sept 2020 | - | $1.05 M(-17.6%) |
| June 2020 | - | $1.27 M(-6.1%) |
| Mar 2020 | - | $1.35 M(-464.6%) |
| Dec 2019 | -$370.90 K | -$370.90 K(+49.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -$248.90 K(+54.7%) |
| June 2019 | - | -$160.90 K(+193.1%) |
| Mar 2019 | - | -$54.90 K(-194.3%) |
| Dec 2018 | $58.20 K(-107.0%) | $58.20 K(-56.7%) |
| Sept 2018 | - | $134.50 K(-62.0%) |
| June 2018 | - | $354.10 K(-35.7%) |
| Mar 2018 | - | $550.50 K(-166.2%) |
| Dec 2017 | -$831.80 K(-737.4%) | -$831.80 K(-2978.2%) |
| Nov 2017 | - | $28.90 K(-104.8%) |
| Sept 2017 | - | -$608.10 K(-1448.3%) |
| Aug 2017 | - | $45.10 K(-51.3%) |
| May 2017 | - | $92.60 K(-29.0%) |
| Feb 2017 | $130.50 K(-130.2%) | $130.50 K(-19.2%) |
| Dec 2016 | -$432.40 K(-2047.7%) | - |
| Nov 2016 | - | $161.50 K(-419.8%) |
| Aug 2016 | - | -$50.50 K(+372.0%) |
| May 2016 | - | -$10.70 K(-148.2%) |
| Feb 2016 | $22.20 K(-156.3%) | $22.20 K(-58.0%) |
| Nov 2015 | - | $52.80 K(-160.0%) |
| Aug 2015 | - | -$88.00 K(+68.3%) |
| May 2015 | - | -$52.30 K(+32.7%) |
| Feb 2015 | -$39.40 K | -$39.40 K |
FAQ
- What is XORTX Therapeutics annual working capital?
- What is the all time high annual working capital for XORTX Therapeutics?
- What is XORTX Therapeutics annual working capital year-on-year change?
- What is XORTX Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly working capital year-on-year change?
What is XORTX Therapeutics annual working capital?
The current annual working capital of XRTX is $3.77 M
What is the all time high annual working capital for XORTX Therapeutics?
XORTX Therapeutics all-time high annual working capital is $15.27 M
What is XORTX Therapeutics annual working capital year-on-year change?
Over the past year, XRTX annual working capital has changed by -$5.58 M (-59.67%)
What is XORTX Therapeutics quarterly working capital?
The current quarterly working capital of XRTX is $693.60 K
What is the all time high quarterly working capital for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly working capital is $15.36 M
What is XORTX Therapeutics quarterly working capital year-on-year change?
Over the past year, XRTX quarterly working capital has changed by -$3.08 M (-81.62%)